[1]
“ Quality of life of HIV+ patients undergoing pharmacotherapeutic follow-up ”, Braz. J. Pharm. Sci., vol. 48, nº 4, p. 711–718, dez. 2012, doi: 10.1590/S1984-82502012000400015.